You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 147 No. 9, September 1993 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Aplastic Anemia in Neonatal Lupus Erythematosus

Baruch Wolach, MD; Luis Choc, MD; Avshalom Pomeranz, MD; Yosef Ben Ari, MD; Danny Douer, MD; Aryeh Metzker, MD

Am J Dis Child. 1993;147(9):941-944.


Abstract



• Objective.
—To describe an infant with neonatal lupus erythematosus associated with aplastic anemia.

Setting.
—The pediatric department in a tertiary-care hospital.

Interventions.
—Packed red blood cell transfusions and a 3-week course of high-dose steroid therapy.

Measurements/Main Results.
—The patient presented with severe anemia and a circumscribed, reticular, macular rash on the face and neck at 5 months of age. Skin lesion biopsy revealed epidermic hyperkeratosis, hydropic degeneration of the basal layer, and deposition of immunoglobulins and granular C1 q at the dermoepidermal junction. Ro/SS-A antibodies were present in the infant. BFU-E (erythyroid progenitor burst-forming unit) colonies in bone marrow increased by about tenfold when suppressor CD8+ T lymphocytes were removed, indicating immune suppression of hematopoiesis. High-dose steroid therapy failed. The infant subsequently developed gram-negative sepsis, severe metabolic acidosis, and consumptive coagulopathy and died.

Conclusions.
—Neonatal lupus erythematosus may present as part of a spectrum. The disease may range from mild and transient to a severe, life-threatening condition requiring immediate intervention, as in the case reported here. This is the first report of neonatal lupus associated with aplastic anemia due to immune-mediated suppression of hematopoiesis.

(AJDC. 1993;147:941-944)



Author Affiliations



From the Department of Pediatrics and the Pediatric Hematology Unit, Meir General Hospital, Sapir Medical Center, Kfar Saba (Drs Wolach, Choc, Pomeranz, and Ben Ari), the Institute of Hematology, Chaim Sheba Medical Center, Tel-Hashomer (Dr Douer), and the Pediatric Dermatology Unit, Children's Medical Center, Petah Tiqva, and the Tel-Aviv University Sackler School of Medicine (Dr Metzker), Israel.


Footnotes



Accepted for publication March 25, 1993.

Reprint requests to Department of Pediatrics, Meir General Hospital, 44281 Kfar Saba, Israel (Dr Wolach).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Infants Born to Mothers With Anti-SSA/Ro Autoantibodies: Neonatal Outcome and Follow-up
Zuppa et al.
CLIN PEDIATR 2008;47:231-236.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.